impact factor
logo
 

Brief Papers

 

Familial clustering of recurrent pericarditis may disclose tumour necrosis factor receptor-associated periodic syndrome


, , , ,

 

CER664
2010 Vol.28, N°3
PI 0405, PF 0407
Brief Papers

Free to view
(click on article PDF icon to read the article)

PMID: 20497634 [PubMed]

Received: 12/10/2009
Accepted : 19/01/2010
In Press: 23/06/2010
Published: 23/06/2010

Abstract

OBJECTIVES:
Although several causes of recurrent pericarditis have been identified, the etiology remains obscure in most cases. The tumour necrosis factor receptor-1 associated periodic syndrome (TRAPS) is the most common autosomal dominant autoinflammatory disorder and is caused by mutations in the TNFRSF1A gene encoding the 55-kD receptor for tumour necrosis factor- (TNF)-a. Serosal membrane inflammation is a common feature of TRAPS, usually in the form of polyserositis. In addition, patients affected with recurrent pericarditis as the only clinical manifestation of TRAPS have been recently described. Our aim was to investigate the possible involvement of mutations in the TNFRSF1A gene in a cohort of patients affected with idiopathic recurrent pericarditis.
METHODS:
Twenty consecutive patients diagnosed with idiopathic recurrent pericarditis were enrolled. Each patient underwent detailed examinations in order to rule out underlying diseases such as infections, connective tissue disorders and malignancies, and mutations of the TNFRSF1A gene were searched for by amplifying, using polymerase chain reaction (PCR), genomic DNA, and direct sequencing.
RESULTS:
TNFRSF1A mutations were found in 2 of the 20 patients. They were siblings, and they both carried a heterozygous low-penetrance R92Q mutation in the TNFRSF1A gene.
CONCLUSIONS:
Familial clustering has been recently reported in up to 10% of patients with recurrent pericarditis, thus suggesting in some cases a possible genetic predisposition. Our study suggests that familial clustering may represent a clue for investigating mutations in the TNFRSF1A gene in these patients and eventually disclose TRAPS.

Rheumatology Article